SiliconBeat

Design Within Reach, the San Francisco provider of hip home furnishings, has told Nasdaq that it plans to delist its shares from the stock market on July 6, after which the company expects them to trade on the Pink Sheets, according to a filing the company made with the SEC Thursday.

The company said that the limited trading Read the rest of this entry »

The Nasdaq stock market has found yet another reason why Spansion’s stock should be delisted, in addition to the facts that the company has filed for bankruptcy and is unable to file its annual 10-K financial report with the Securities and Exchange Commission. Spansion has also failed to pay the necessary fees for continued listing, according to a press release it distributed via PRNewswire.

Good luck with that appeal, which the company says it plans to make.

Insite Vision, the Alameda maker of ophthalmology products, was told last week that the company’s appeal of its proposed delisting by the NYSE Amex stock exchange was denied. Beginning Monday, April 20, Insite’s shares will begin trading on the Over-the-Counter Bulletin Board and Pink Sheets listings.

Insite was no longer in compliance with listing requirements because of insufficient shareholder equity and too many operating losses in recent years, according to a regulatory filing Tuesday.

Shares of Electroglas, the San Jose maker of chip manufacturing equipment that is struggling to stay afloat during the worst downturn ever for chip makers and the company’s that serve them, will no longer be traded on Nasdaq as of Monday morning.

The delisting follows the withdrawal by the company of its Read the rest of this entry »

Silicon Graphics will have its shares delisted from the Nasdaq stock market beginning Thursday morning, according to an SEC filing it made Monday. The news was delivered last week to the Sunnyvale computer maker in a letter from Nasdaq that said the company had failed to become compliant with a rule that the company maintain Read the rest of this entry »

In response to a notice it got Feb. 18 from Nasdaq that its shareholder equity as of Dec. 31 was below the stock market’s $10 million minimum, Pharmacyclics said in a filing today it was submitting a plan today “to achieve and sustain compliance with the continued listing requirements.”

The Sunnyvale pharmaceutical’s stockholders’ equity on Dec. 31, 2008 was $8,032,000, but did not include the effects of the $5 million loan the company received from its chief executive, Robert Duggan, nor its recently completed sale $1.4 million worth of stock.

Avistar Communications was warned again by Nasdaq last month that its shares are at risk of being delisted from its stock market listings. It was warned earlier this year that its stock would be delisted unless it could lift its per-share price above $1, which it finally managed to do on a consistent enough basis in August, when it won a reprieve from Nasdaq.

Now the San Mateo supplier of desktip videonconferencing and online collaboration tools, which has been in an intellectual property battle with Microsoft over numerous patents has seen its market value sink below Read the rest of this entry »

Quantum (NYSE:QTM), the San Jose maker of storage products, received word from the New York Stock Exchange that it is “not in compliance” with its minimum $1 listing requirement. It has until Nov. 10 to explain to the stock market its plans for rectifying the situation, and it will have until April 29 to comply with the order by having its shares trade above $1 for 30 consecutive days, according to a filing today.

The company said in a release that should it be unable to lift its shares above the required minimum, it Read the rest of this entry »

In the world of reverse-splits, it rarely gets as dramatic as this. BroadVision of Redwood City said Friday it completed its 1-for-25 split, meaning that shareholders received one new post-split share in exchange for every 25 they owned. Fractional shares will be paid out in cash.

The change will be reflected when the markets open Monday. Broadvision shares (ticker:BVSN) closed Friday at 48 cents each, which will be equal to Read the rest of this entry »

Shares of Vermillion, the Fremont company formerly known as Ciphergen Biosystems that develops medical diagnostic tests, were delisted from the Nasdaq stock market last week after failing to lift its stockholder equity above the minimum level required for continued listing. Its shares (ticker: VRML) can now be found in the Pink Sheets, an electronic quotation service for stocks traded over-the-counter, according to a company filing Thursday.

In July, Vermillion agreed to pay ThinkPanmure, a San Francisco “global growth company” investment banking firm, a $150,000 retainer out of its $5 million in remaining cash Read the rest of this entry »